Dr. Martens plc (LON:DOCS)
London · Delayed Price · Currency is GBP · Price in GBX 72.00
+0.80 (1.12%)
Sep 4, 2026, 4:35 PM GMT
Dr. Martens Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 764.9 | 787.6 | 877.1 | 1,000 | 908.3 | |
Revenue Growth | -2.88% | -10.20% | -12.32% | 10.13% | 17.50% |
Cost of Revenue | 258.9 | 275.9 | 301.9 | 382.2 | 329.5 |
Gross Profit | 506 | 511.7 | 575.2 | 618.1 | 578.8 |
Selling, General & Admin | 365.9 | 378.4 | 377.7 | 373.1 | 315.8 |
Amortization of Goodwill & Intangibles | 6.3 | 6.1 | 5.8 | 8.4 | 4.7 |
Other Operating Expenses | -0.7 | 0.1 | -1.2 | - | - |
Operating Expenses | 433.6 | 451 | 448.8 | 427.3 | 352.3 |
Operating Income | 72.4 | 60.7 | 126.4 | 190.8 | 226.5 |
Interest Expense | -27.7 | -30.2 | -32.2 | -18.7 | -15.5 |
Interest & Investment Income | 3.7 | 3.8 | 3 | 1.9 | 0.1 |
Currency Exchange Gain (Loss) | 0.9 | -3.1 | -4.2 | -10.7 | 3.2 |
Other Non Operating Income (Expenses) | -0.3 | -0.2 | - | - | 0.4 |
EBT Excluding Unusual Items | 49 | 31 | 93 | 163.3 | 214.7 |
Merger & Restructuring Charges | -0.4 | -11.7 | - | - | - |
Asset Writedown | -4.2 | -4.3 | - | -3.9 | -0.4 |
Other Unusual Items | -11.7 | -6.2 | - | - | - |
Pretax Income | 32.7 | 8.8 | 93 | 159.4 | 214.3 |
Income Tax Expense | 8.9 | 4.3 | 23.8 | 30.5 | 33.1 |
Net Income | 23.8 | 4.5 | 69.2 | 128.9 | 181.2 |
Net Income to Common | 23.8 | 4.5 | 69.2 | 128.9 | 181.2 |
Net Income Growth | 428.89% | -93.50% | -46.31% | -28.86% | 422.19% |
Shares Outstanding (Basic) | 965 | 962 | 984 | 1,001 | 1,000 |
Shares Outstanding (Diluted) | 980 | 974 | 986 | 1,001 | 1,003 |
Shares Change | 0.56% | -1.17% | -1.56% | -0.17% | 0.25% |
EPS (Basic) | 0.02 | 0.00 | 0.07 | 0.13 | 0.18 |
EPS (Diluted) | 0.02 | 0.00 | 0.07 | 0.13 | 0.18 |
EPS Growth | 413.26% | -93.32% | -45.67% | -28.82% | 421.61% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 133.5 | 187.9 | 149.7 | 33.1 | 168.9 |
Free Cash Flow Per Share | 0.14 | 0.19 | 0.15 | 0.03 | 0.17 |
Dividend Per Share | 0.025 | 0.025 | 0.025 | 0.058 | 0.055 |
Dividend Growth | 0% | 0% | -56.34% | 6.18% | - |
Gross Margin | 66.15% | 64.97% | 65.58% | 61.79% | 63.72% |
Operating Margin | 9.46% | 7.71% | 14.41% | 19.07% | 24.94% |
Profit Margin | 3.11% | 0.57% | 7.89% | 12.89% | 19.95% |
Free Cash Flow Margin | 17.45% | 23.86% | 17.07% | 3.31% | 18.59% |
EBITDA | 85.7 | 75.7 | 141.7 | 204.4 | 236 |
EBITDA Margin | 11.20% | 9.61% | 16.16% | 20.43% | 25.98% |
D&A For EBITDA | 13.3 | 15 | 15.3 | 13.6 | 9.5 |
EBIT | 72.4 | 60.7 | 126.4 | 190.8 | 226.5 |
EBIT Margin | 9.46% | 7.71% | 14.41% | 19.07% | 24.94% |
Effective Tax Rate | 27.22% | 48.86% | 25.59% | 19.13% | 15.45% |